Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. JOC [Internet]. 2006 Feb. 28 [cited 2025 Dec. 7];5(1). Available from: https://carcinogenesis.com/index.php/JOC/article/view/227